Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tito Fojo

Showing results (141-150 of 237) with videos related to

Pageof 24
Sort By:
Journal of Vascular and Interventional Radiology : JVIR|October 31, 2009
Radiofrequency ablation of metastatic pheochromocytomaAradhana M Venkatesan, Julia Locklin, Edwin W Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576Manish Agrawal, Jame Abraham, Frank M Balis, et al.
Molecular Cancer Therapeutics|December 17, 2002
Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicityMikhail V Blagosklonny, Robert Robey, Dan L Sackett, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 4, 2017
Anti-Hu paraneoplastic brainstem encephalitis caused by a pancreatic neuroendocrine tumor presenting with central hypoventilationMarc Najjar, Andrew Taylor, Surbhi Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2012
Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growthWilfred D Stein, Julia Wilkerson, Sindy T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinomaHui Huang, Michael Menefee, Maureen Edgerly, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2002
Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamicsParaskevi Giannakakou, Michel Nakano, Kyriacos C Nicolaou, et al.
The Annals of Thoracic Surgery|October 1, 2011
Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experienceClinton D Kemp, R Taylor Ripley, Aarti Mathur, et al.
The Oncologist|July 7, 2017
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell CarcinomaMauricio Burotto, Maureen Edgerly, Margarita Velarde, et al.
Cancer Research|August 17, 2005
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitorsMikhail V Blagosklonny, Shana Trostel, Ganesh Kayastha, et al.
Pageof 24

Showing results (141-150 of 237) with videos related to

Sort By:
Pageof 24
Journal of Vascular and Interventional Radiology : JVIR|October 31, 2009
Radiofrequency ablation of metastatic pheochromocytomaAradhana M Venkatesan, Julia Locklin, Edwin W Lai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576Manish Agrawal, Jame Abraham, Frank M Balis, et al.
Molecular Cancer Therapeutics|December 17, 2002
Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicityMikhail V Blagosklonny, Robert Robey, Dan L Sackett, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 4, 2017
Anti-Hu paraneoplastic brainstem encephalitis caused by a pancreatic neuroendocrine tumor presenting with central hypoventilationMarc Najjar, Andrew Taylor, Surbhi Agrawal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2012
Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growthWilfred D Stein, Julia Wilkerson, Sindy T Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 25, 2010
A phase II clinical trial of ixabepilone (Ixempra; BMS-247550; NSC 710428), an epothilone B analog, in patients with metastatic renal cell carcinomaHui Huang, Michael Menefee, Maureen Edgerly, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 30, 2002
Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamicsParaskevi Giannakakou, Michel Nakano, Kyriacos C Nicolaou, et al.
The Annals of Thoracic Surgery|October 1, 2011
Pulmonary resection for metastatic adrenocortical carcinoma: the National Cancer Institute experienceClinton D Kemp, R Taylor Ripley, Aarti Mathur, et al.
The Oncologist|July 7, 2017
A Phase II Multi-Center Study of Bevacizumab in Combination with Ixabepilone in Subjects with Advanced Renal Cell CarcinomaMauricio Burotto, Maureen Edgerly, Margarita Velarde, et al.
Cancer Research|August 17, 2005
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitorsMikhail V Blagosklonny, Shana Trostel, Ganesh Kayastha, et al.
Pageof 24